Condition
Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 clinical trials that are recruiting, in United States. By phase: Phase 1 (1), Phase 2 (1), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Camonsertib added to precise radiation therapy for recurrent head and neck cancer | Phase 1 | Duarte, California and 3 other locations | Recruiting | Sep 5, 2025 |
| High-dose gabapentin versus placebo to prevent opioid use for mouth pain during chemoradiation for head and neck cancer | Phase 3 | Gilbert, Arizona and 215 other locations | Recruiting | May 28, 2025 |
| Adding BMX-001, a drug that protects normal tissue from radiation damage, to standard chemoradiation for head and neck cancer | Phase 2 | Gilbert, Arizona and 152 other locations | Recruiting | Aug 1, 2024 |
| Personalized vaccine combined with pembrolizumab for advanced solid tumors | Phase 1/2 | Jacksonville, Florida | Recruiting | Mar 8, 2022 |
All recruiting trials (4)
-
Camonsertib added to precise radiation therapy for recurrent head and neck cancer
This early-phase study tests whether the cancer drug camonsertib, given with targeted SBRT radiation, is safe and tolerable for people with recurrent or unresectable head and neck squamous cell carcinoma.
-
High-dose gabapentin versus placebo to prevent opioid use for mouth pain during chemoradiation for head and neck cancer
This will test whether taking high-dose gabapentin during cisplatin chemoradiation for head and neck cancer helps people avoid needing opioid pain medicine for painful mouth sores.
-
Adding BMX-001, a drug that protects normal tissue from radiation damage, to standard chemoradiation for head and neck cancer
This trial tests whether giving BMX-001 along with usual mouth-care reduces severe mouth sores in people getting cisplatin-based chemoradiation for HPV-related and other head and neck cancers.
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
Related topics
Quick answers
How many Stage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.